The biomechanics and prevention of vein graft failure in coronary revascularization

Abstract

Saphenous vein grafts (SVGs) are the most widely used conduit in coronary artery bypass grafting (CABG) surgery; however, SVG failures due to neointimal hyperplasia present a significant long-term limitation to the effectiveness of myocardial revascularization. This review will provide a comprehensive overview of the biological mechanisms of vein graft failure, including compensatory endothelial proliferation, extracellular matrix deposition, and adventitial disruption. We will discuss historical and emerging strategies for vein graft failure prevention with a focus on the role of mechanical vein graft support using external stenting. Finally, we will highlight the results of preclinical and human trials and discuss future directions for investigation.

Keywords

Coronary artery bypass grafting / saphenous vein / vein graft failure / neointimal hyperplasia / external stenting / vein graft remodeling

References

[1] Virani SS,Benjamin EJ.On behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics - 2020 update: a report from the American Heart Association.Circulation2020;141:e139-596

[2] Sabik JF,Blackstone EH,Cosgrove DM.Comparison of saphenous vein and internal thoracic artery graft patency by coronary system.Ann Thorac Surg2005;79:544-51

[3] Bourassa MG,Campeau L,McConney M.Long-term fate of bypass grafts: the coronary artery surgery study (CASS) and montreal heart institute experiences.Circulation1985;72:V71-8

[4] Favaloro RG.Saphenous vein graft in the surgical treatment of coronary artery disease. Operative technique.J Thorac Cardiovasc Surg1969;58:178-85.

[5] Schwann TA,Wallace A.Operative outcomes of multiple-arterial versus single-arterial coronary bypass grafting.Ann Thorac Surg2018;105:1109-19

[6] Mckavanagh P,Zawadowski G.Management and prevention of saphenous vein graft failure: a review.Cardiol Ther2017;6:203-23 PMCID:PMC5688971

[7] Loop FD,Cosgrove DM.Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events.N Engl J Med1986;314:1-6

[8] Fitzgibbon GM,Leach AJ,Hooper G.Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years.J Am Coll Cardiol1996;28:616-26

[9] Gaudino M,Fremes S.Association of radial artery graft vs saphenous vein graft with long-term cardiovascular outcomes among patients undergoing coronary artery bypass grafting: a systematic review and meta-analysis.JAMA2020;324:179-87 PMCID:PMC7361649

[10] Locker C,Dearani JA.Multiple arterial grafts improve late survival of patients undergoing coronary artery bypass graft surgery: analysis of 8622 patients with multivessel disease.Circulation2012;126:1023-30

[11] Takagi H,Watanabe T,Kawai N.A meta-analysis of adjusted hazard ratios from 20 observational studies of bilateral versus single internal thoracic artery coronary artery bypass grafting.J Thorac Cardiovasc Surg2014;148:1282-90

[12] Lytle BW,Taylor PC.Vein graft disease: the clinical impact of stenoses in saphenous vein bypass grafts to coronary arteries.J Thorac Cardiovasc Surg1992;103:831-40.

[13] Halabi AR,Shaw LK.Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery.Am J Cardiol2005;96:1254-9

[14] Lopes RD,Hafley GE.Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery.Circulation2012;125:749-56 PMCID:PMC3699199

[15] Violaris AG,Angelini GD.Effects of external stenting on wall thickening in arteriovenous bypass grafts.Ann Thorac Surg1993;55:667-71

[16] Zwolak RM,Clowes AW.Kinetics of vein graft hyperplasia: association with tangential stress.J Vasc Surg198;5:126-36

[17] Kohler TR,Clowes AW.The effect of rigid external support on vein graft adaptation to the arterial circulation.J Vasc Surg1989;9:277-85

[18] Izzat MB,Bryan AJ,Newby AC.Influence of external stent size on early medial and neointimal thickening in a pig model of saphenous vein bypass grafting.Circulation1996;94:1741-5

[19] Mehta D,Jeremy JY.External stenting reduces long-term medial and neointimal thickening and platelet derived growth factor expression in a pig model of arteriovenous bypass grafting.Nat Med1998;4:235-9

[20] Parsonnet V,Shah IH.New stent for support of veins in arterial grafts.Arch Surg1963;87:696-702

[21] Liao SW,Putnam AJ.A novel time-varying poly lactic-co glycolic acid external sheath for vein grafts designed under physiological loading.Tissue Eng2007;13:2855-62

[22] Jeremy JY,Johnson JL.A bioabsorbable (polyglactin), nonrestrictive, external sheath inhibits porcine saphenous vein graft thickening.J Thorac Cardiovasc Surg2004;127:1766-72

[23] Vijayan V,Johnson JL.Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath.J Vasc Surg2004;40:1011-9

[24] Ku DN,Zarins CK.Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress.Arteriosclerosis1985;5:293-302

[25] Lee SW,Steinman DA.Correlations among indicators of disturbed flow at the normal carotid bifurcation.J Biomech Eng2009;131:061013

[26] Meirson T,Avrahami I.Numerical analysis of venous external scaffolding technology for saphenous vein grafts.J Biomech2015;48:2090-5

[27] Meirson T,Di Mario C.Flow patterns in externally stented saphenous vein grafts and development of intimal hyperplasia.J Thorac Cardiovasc Surg2015;150:871-9

[28] Amin S,Madsen PL,Taggart DP.Influence of external stenting on venous graft flow parameters in coronary artery bypass grafting: a randomized study.Interact Cardiovasc Thorac Surg2018;26:926-31

[29] Ramachandra AB,Humphrey JD.Computational simulation of the adaptive capacity of vein grafts in response to increased pressure.J Biomech Eng2015;137:031009 PMCID:PMC4321118

[30] Ramachandra AB,Marsden AL.Gradual loading ameliorates maladaptation in computational simulations of vein graft growth and remodelling.J R Soc Interface2017;14:20160995 PMCID:PMC5454282

[31] Ramachandra AB,Wnorowski A.Biodegradable external wrapping promotes favorable adaptation in an ovine vein graft model.Acta Biomater2022;151:414-25 PMCID:PMC9759202

[32] Longchamp A,Dubuis C.The use of external mesh reinforcement to reduce intimal hyperplasia and preserve the structure of human saphenous veins.Biomaterials2014;35:2588-99

[33] Ben-gal Y,Williams MR.Expandable external support device to improve Saphenous Vein Graft Patency after CABG.J Cardiothorac Surg2013;8:122 PMCID:PMC3661403

[34] Sato A,Watanabe M.A novel biodegradable external mesh stent improved long-term patency of vein grafts by inhibiting intimal–medial hyperplasia in an experimental canine model.Gen Thorac Cardiovasc Surg2016;64:1-9

[35] El-kurdi MS,Stankus JJ,Wagner WR.Transient elastic support for vein grafts using a constricting microfibrillar polymer wrap.Biomaterials2008;29:3213-20 PMCID:PMC2486447

[36] El-kurdi M,Mcgrath J.Functional remodeling of an electrospun polydimethylsiloxane-based polyether urethane external vein graft support device in an ovine model.J Biomed Mater Res2019;107:2135-49 PMCID:PMC6689261

[37] Yasuda S,Shibuya T.An appropriately sized soft polyester external stent prevents enlargement and neointimal hyperplasia of a saphenous vein graft in a canine model.Artif Organs2019;43:577-83

[38] Abbasi K,Anvari MS.Perivascular nitric oxide delivery to saphenous vein grafts prevents graft stenosis after coronary artery bypass grafting: a novel sheep model.Cardiology2011;118:8-15

[39] Handa M,Morioka K,Yamada N.Adventitial delivery of platelet-derived endothelial cell growth factor gene prevented intimal hyperplasia of vein graft.J Vasc Surg2008;48:1566-74

[40] Nishio H,Sakamoto K,Ikeda T.MicroRNA-145-loaded poly(lactic-co-glycolic acid) nanoparticles attenuate venous intimal hyperplasia in a rabbit model.J Thorac Cardiovasc Surg2019;157:2242-51

[41] Kahraman N,Gücü A.Administration of perivascular cyanoacrylate for the prevention of cellular damage in saphenous vein grafts: an experimental model.Cardiovasc J Afr2016;27:159-63 PMCID:PMC5101453

[42] Dai L,Gu C,Yu Y.Perivenous application of cyanoacrylate tissue sealants reduces intimal and medial thickening of the vein graft and inflammatory responses in a rabbit model of carotid artery bypass grafting.Eur J Cardiothorac Surg2016;49:675-81

[43] Bahcivan M,Kefeli M,Can B.Inhibition of vein graft intimal hyperplasia by periadventitial application of hyaluronic acid-carboxymethyl cellulose: an experimental study.Scand Cardiovasc J2008;42:161-5

[44] Salinas HM,Mccormack MC.Prevention of vein graft intimal hyperplasia with photochemical tissue passivation.J Vasc Surg2017;65:190-6

[45] Alexander JH,Harrington RA.PREVENT IV InvestigatorsEfficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial.JAMA2005;294:2446-54

[46] Lopes RD,Mehta RH.Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of ex-vivo vein graft ENgineering via transfection IV (PREVENT IV) 5-year results.Am Heart J2012;164:379-86.e1 PMCID:PMC3677726

[47] Murphy GJ,Jeremy JY,Angelini GD.A randomized trial of an external Dacron sheath for the prevention of vein graft disease: the extent study.J Thorac Cardiovasc Surg2007;134:504-5

[48] Schoettler J,Grothusen C.Highly flexible nitinol mesh to encase aortocoronary saphenous vein grafts: first clinical experiences and angiographic results nine months postoperatively.Interact Cardiovasc Thorac Surg2011;13:396-400

[49] Inderbitzin DT,Matt P,Eckstein FS.One-year patency control and risk analysis of eSVS®-mesh-supported coronary saphenous vein grafts.J Cardiothorac Surg2015;10:108 PMCID:PMC4529720

[50] Taggart DP,Lees B.A randomized trial of external stenting for saphenous vein grafts in coronary artery bypass grafting.Ann Thorac Surg2015;99:2039-45

[51] Taggart DP,Djordjevic J.A prospective study of external stenting of saphenous vein grafts to the right coronary artery: the VEST II study.Eur J Cardiothorac Surg2017;51:952-8

[52] Taggart DP,Desouza A.Long-term performance of an external stent for saphenous vein grafts: the VEST IV trial.J Cardiothorac Surg2018;13:117 PMCID:PMC6245530

[53] Taggart DP,Krasopoulos G.External stenting and disease progression in saphenous vein grafts two years after coronary artery bypass grafting: a multicenter randomized trial.J Thorac Cardiovasc Surg2022;164:1532-41.e2

[54] Icahn School of Medicine at Mount Sinai. A multi-center, randomized, within-subject-controlled, open label study of the safety and effectiveness of vest, venous external support. (VEST Pivotal). Identifier: NCT03209609. Available from: https://clinicaltrials.gov/study/NCT03209609 [Last accessed on 13 Dec 2023]